For Immediate Release
Press contact: Kristin Jones, IHIF
Tel: 317-524-4769 or email@example.com
INDIANAPOLIS (May 6, 2014) – The Indiana Health Industry Forum (IHIF), the state’s trade association for companies in the health science sector, and BIO, the international industry association for the biotechnology industry, today recognized Representative Ed Clere and Senator Brandt Hershman as 2014 Legislators of the Year, for their work on recent biosimilar substitution legislation. The award is given to public officials who demonstrate a commitment to excellence in public health policy and service to Indiana’s health science business community.
Representative Ed Clere (District 72), is Chair of the House Committee on Public Health, which initiated the legislation in the 2013 session. Senator Hershman (District 7), is the Majority Floor Leader and sponsor of SB 262 in the 2014 session. The bill passed Indiana’s Senate and House of Representatives by wide margins and was signed into law by Governor Pence earlier this year.
While the U.S. Food and Drug Administration (FDA) oversees approval of biologic medicines and designation of interchangeability, policies governing whether one product may be substituted in place of a doctor’s prescription and whether a pharmacist must inform patients and doctors are covered by state law. Senate Bill 262 sought to properly preserve patient access to accurate prescription information, maintains incentives for innovation and promotes a competitive market for biologic therapies.
IHIF President and CEO, Kristin Jones, said, “We are pleased to have the opportunity today to recognize the contribution Representative Clere and Senator Hershman have made to advancing patient safety and promoting innovation in Indiana. Indiana is now a national leader in providing access to these life-saving and life-changing therapies to patients in need.”
The award was presented at today’s IHIF 2014 Annual Meeting, which also celebrated the 20th Anniversary of the organization.
The diverse members of the Indiana Health Industry Forum generate the collective voice of the state’s health and life science industry. The Forum connects key stakeholders to enhance business networks, advocate for member interests, develop workforce skills, and provide strategic vision in the interest of growing the state’s health industry economy and reputation. IHIF is the Indiana affiliate of the Biotechnology Industry Organization. To learn more, please visit www.ihif.org